KLF5 and prostate cancer: We found that in Pten-null mouse prostate tumors, deletion of Klf5 significantly promoted angiogenesis, and conditioned media from human prostate cancer cells with modulated KLF5 expression affected tube formation and migration of human umbilical vein endothelial cells (HuVECs).